BioCentury | Apr 24, 2020
Emerging Company Profile

FoRx: A broader look at DNA damage repair

...scientific director at the EMD Serono Inc. unit of Merck KGaA (Xetra:MRK) and CSO at Metabomed Ltd....
BioCentury | Jun 22, 2017
Emerging Company Profile

Repare in progress

...Inc. is using a CRISPR-based screen to find synthetic lethal combinations. Ideaya Biosciences Inc. and Metabomed Ltd....
...Ltd., Cambridge U.K. Ideaya Biosciences Inc., South San Francisco, Calif. Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario Metabomed Ltd....
BioCentury | Mar 31, 2017
Finance

It takes two

...technologies or approaches they are taking. At least three raised series A funding last year: Metabomed Ltd....
BioCentury | Apr 11, 2016
Financial News

Metabomed financial update

...Metabomed Ltd. , Yavne, Israel Business: Cancer Date announced: 2016-04-04 Note: Metabomed raised an undisclosed amount...
BioCentury | Apr 5, 2016
Financial News

Metabomed caps $18M series A

...Cancer play Metabomed Ltd. (Yavne, Israel) said it raised an undisclosed amount in an extension of its...
...MS Ventures, Boehringer Ingelheim Venture Fund, Pontifax Fund and the Technion Research and Development Foundation. Metabomed...
...a synthetic lethal gene pair with metabolic genes inactivated in cancer cells. MS Ventures was Metabomed's...
BioCentury | Dec 9, 2013
Financial News

Metabomed completes venture financing

Metabomed Ltd. , Yavne, Israel Business: Cancer Date completed: 11/26/13 Type: Venture financing Raised: Not disclosed Investors: MS Ventures; Boehringer Ingelheim Venture Fund; Pontifax; Technion Research and Development Foundation WIR Staff cancer...
BioCentury | Nov 27, 2013
Financial News

Merck Serono's Israeli incubator debuts two newcos

...MS Ventures, the strategic corporate fund of the Merck Serono division of Merck KGaA (Xetra:MRK). Metabomed Ltd....
...Boehringer Ingelheim Venture Fund; Pontifax Fund; and Technion Research and Development Foundation also participated in Metabomed's...
Items per page:
1 - 7 of 7
BioCentury | Apr 24, 2020
Emerging Company Profile

FoRx: A broader look at DNA damage repair

...scientific director at the EMD Serono Inc. unit of Merck KGaA (Xetra:MRK) and CSO at Metabomed Ltd....
BioCentury | Jun 22, 2017
Emerging Company Profile

Repare in progress

...Inc. is using a CRISPR-based screen to find synthetic lethal combinations. Ideaya Biosciences Inc. and Metabomed Ltd....
...Ltd., Cambridge U.K. Ideaya Biosciences Inc., South San Francisco, Calif. Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario Metabomed Ltd....
BioCentury | Mar 31, 2017
Finance

It takes two

...technologies or approaches they are taking. At least three raised series A funding last year: Metabomed Ltd....
BioCentury | Apr 11, 2016
Financial News

Metabomed financial update

...Metabomed Ltd. , Yavne, Israel Business: Cancer Date announced: 2016-04-04 Note: Metabomed raised an undisclosed amount...
BioCentury | Apr 5, 2016
Financial News

Metabomed caps $18M series A

...Cancer play Metabomed Ltd. (Yavne, Israel) said it raised an undisclosed amount in an extension of its...
...MS Ventures, Boehringer Ingelheim Venture Fund, Pontifax Fund and the Technion Research and Development Foundation. Metabomed...
...a synthetic lethal gene pair with metabolic genes inactivated in cancer cells. MS Ventures was Metabomed's...
BioCentury | Dec 9, 2013
Financial News

Metabomed completes venture financing

Metabomed Ltd. , Yavne, Israel Business: Cancer Date completed: 11/26/13 Type: Venture financing Raised: Not disclosed Investors: MS Ventures; Boehringer Ingelheim Venture Fund; Pontifax; Technion Research and Development Foundation WIR Staff cancer...
BioCentury | Nov 27, 2013
Financial News

Merck Serono's Israeli incubator debuts two newcos

...MS Ventures, the strategic corporate fund of the Merck Serono division of Merck KGaA (Xetra:MRK). Metabomed Ltd....
...Boehringer Ingelheim Venture Fund; Pontifax Fund; and Technion Research and Development Foundation also participated in Metabomed's...
Items per page:
1 - 7 of 7